Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8674221 | Molecular Metabolism | 2018 | 10 Pages |
Abstract
Loss or impairment of SGLT1 results in abnormal pancreatic islet (cyto)morphology and disturbed islet function regarding the insulin or glucagon release capacity from β- or α-cells, respectively. Consequently, our findings propose a new, additional role for SGLT1 maintaining proper islet structure and function.
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
Markus Mühlemann, Daniela Zdzieblo, Alexandra Friedrich, Constantin Berger, Christoph Otto, Heike Walles, Hermann Koepsell, Marco Metzger,